Introduction
Upon blood vessel injury, circulating platelets interact with exposed subendothelial collagen through the collagen receptor glycoprotein VI (GPVI). This 65-kDa immune receptor signals through its associated Fc-receptor γ-chain, which contains an immunoreceptor tyrosinebased activation motif (ITAM) in its intracellular domain. Binding of GPVI to collagen induces phosphorylation of the ITAM residues, which can then bind to Syk, itself becoming phosphorylated and activated. This process initiates signalosome assembly [1] , leading to a series of downstream signals, resulting in platelet activation, finally culminating in thrombus formation.
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GPVI contains two extracellular Ig-like domains: D1 containing the collagen binding site [2, 3] and D2, connected via an O-glycosylated stem to its transmembrane domain and short cytoplasmic tail [4] . GPVI binds to tandem GPO (glycine-proline-hydroxyproline) sequences in collagen [5, 6] . Surface plasmon resonance showed that dimerized recombinant GPVI (D1D2-Fc) 2 bound collagen fibres with high affinity but binding of its monomeric form (D1D2) was too low to measure [7] . Monomeric and dimeric recombinant D1D2 showed similar affinity for collagen-related peptide (CRP), a triple-helical peptide containing 10 contiguous GPO triplets, suggesting GPVI-dimer may have a specific conformation that recognizes the higher-order structure of fibrous collagen, beyond simply the GPO sequences. The crystal structure of a D1D2 dimeric assembly [8] allowed docking simulations [3, 5, 8] which suggested that D1 contained grooves large enough to accommodate the triple-helical CRP.
In 2009, Jung et al. provided direct evidence for the presence of dimers on the resting platelet surface with GPVI-dimer specific, inhibitory m-Fab-F [9] . Later, they reported a noninhibitory Fab, 204-11, which recognized GPVI-dimers [10] , and used it to show that GPVIdimers were constitutively present on resting platelets. These observations suggested that the first interaction in collagen-induced activation of platelets is collagen binding to GPVIdimers. Several groups, however, reported that platelet activation induced formation of GPVI-dimers. Arthur et al. (11) provided biochemical evidence for disulphide-linked dimers in activated platelets. Loyau et al., employing GPVI-dimer-specific mab 9E18, reported that GPVI dimerization was induced by soluble agonists or VWF, with almost no dimersdetected on resting platelets [12] , leading them to propose dimer formation as a means to control collagen-induced platelet activation. Dimerization is an accepted mechanism for cell activation through receptor tyrosine kinases [13] , where ligand binding to the receptor extracellular domains induces dimerization, causing a conformational change that brings together the kinase domains in the cytoplasmic tails, facilitating autophosphorylation, thereby initiating intracellular signals. The Src-family kinase Lyn associates with the cytoplasmic tail of GPVI [14] , which lacks intrinsic kinase activity, so that FcRγ attached to one GPVI
This article is protected by copyright. All rights reserved. An alternative activation mechanism would be higher-order receptor clustering [15] , which does not preclude the presence of constitutive GPVI-dimers in non-activated platelets.
Clustering has been demonstrated for many classes of receptor, including G proteincoupled receptors [16] ; adhesion receptors such as platelet integrin αIIbβ3 [17] ; platelet CLEC-2 [18] and notably, the discoidin domain receptor, DDR1, a constitutively-dimeric tyrosine kinase receptor for collagen [19] .
As GPVI dimers are present on resting platelets we hypothesize that a further level of control is required. We hypothesize that clustering of GPVI-dimers is a plausible mechanism to modulate platelet activation once the high-affinity, but low-copy-number, GPVI-dimers engage the limited number of binding sites on collagen [2, 20] . The formation of GPVI clusters could result in increased avidity and may bring associated signalling molecules together to facilitate platelet activation. We used complementary imaging techniques to test this hypothesis: TIRFM (Total Internal Reflection Fluorescence Microscopy), to visualize in real-time GPVI-dimer distribution at the interface between the platelet membrane and immobilized collagenous substrates; dSTORM (Direct Stochastic Optical Reconstruction Microscopy) for relative quantification of GPVI cluster size and density; and confocal microscopy to compare localization of GPVI-dimers and two other receptors involved in the platelet-collagen interaction, GPIb and integrin α2β1, and whether signalling was associated with the clustered GPVI-dimers.
Materials and methods
Non-inhibitory, recombinant dimer-specific 204-11 Fab [10] was derived from clone 204-11 [21] by Kaketsuken (Kumamoto, Japan). Antibodies were fluorescently labelled by a Microscale Protein Labelling kit (Molecular Probes); degree of fluorescent labelling =2-5 dye
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molecules/protein molecule. 4G10 (anti-phosphotyrosine; Millipore Merck); Anti-human CD42b/GPIb, clone 486805 (R&D Systems); 16B4 (mouse anti-human CD49b/integrin α2 chain; AbD Serotec); Alexafluor 647-conjugated AffiniPure F(ab')2 fragment goat antimouse IgG, Fcγ-specific (Jackson); Gi9 (anti-integrin α2; Abcam), Alexafluor 647-antihuman CD62P (Bio-Rad). Other materials, reagent grade or better, were obtained from commercial sources.
Platelet preparation
Washed platelets were prepared from ACD-anti-coagulated blood from healthy volunteers (22) 
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by preincubating platelets with 10 μg/ml Gi9 blocking antibody. Platelet morphology was followed using differential interference contrast (DIC) microscopy dSTORM Alexafluor 647-204-11 Fab-labelled washed platelets were allowed to adhere to collagenous-substrate-coated MatTek dishes. Adhered platelets were fixed, permeabilised and stained with Phalloidin-Alexa488. Samples were imaged in switching buffer as described previously (22) 
Confocal imaging
Platelets were preincubated with Alexa 488 or 647-conjugated 204-11 Fab (4 μg/ml) alone or with another fluorescently labelled antibody. In some experiments, platelets were also treated with an inhibitor or inhibitory antibody. The platelets were allowed to adhere to a collagenous substrate, fixed and imaged with an FV300 IX81 Laser-scanning confocal microscope, 60x oil immersion objective (Olympus). Where indicated, platelets were permeabilized (0.1% Triton/PBS) following fixation and stained for actin (Alexafluor 647-Phalloidin) or phosphotyrosine (4G10,5 μg/ml).
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Flow cytometry to measure GPVI-dimers
Washed platelets were pre-incubated with DMSO (0.25% final concentration) or actin antagonist (cytochalasin D, latrunculin A, or jasplakinolide; 10 µM; 0.25% DMSO, final concentration), and GPVI-dimer formation was measured by flow cytometry [10] .
Data analyses
Data analyses,performed with Prism v7 (GraphPad, San Diego, CA), are described in the figure legends. Differences among treatment groups in the flow cytometry experiments were calculated by paired t-test. dSTORM cluster analysis was performed within MATLAB for each 3 x 3 µm ROI (region of interest) as described by Owen et al. [23] with modifications described in Pollitt et al. [18] . Platelets were identified by phalloidin staining of the actin cytoskeleton. ROIs were positioned within the platelet ensuring that the edges of the ROI fell within the platelet boundary. Clusters of <3 points were discounted. The numerical data, processed using Microsoft Excel, were analysed as detailed in the figure legends. The degree of colocalization between the GPVI and phophotyrosine confocal images was quantified by Image-Pro Premiere 9.2 (Molecular Cybernetics).
Results

TIRFM imaging of GPVI-dimer-cluster formation in live platelets interacting with immobilized collagenous substrates
We investigated the spatial and temporal distribution of GPVI dimers on the surface of platelets interacting with different immobilized collagenous substrates (Table I) . Washed platelets labelled for GPVI-dimer were allowed to adhere, and cluster formation and dynamics were visualized by TIRFM ( Fig.1 ; supplemental movie). Discrete clustered GPVI-
Accepted Article
dimers can be visualized in spreading platelets, whereas non-clustered GPVI-dimers are poorly-resolved, appearing as diffuse fluorescence over the platelet surface.
GPVI dimers form clusters on platelets adhering to all collagenous substrates tested.
Cluster formation on fibrous Horm collagen (Horm) follows a distinct distribution, concentrated along the collagen fibre ( Fig 
Different collagenous substrates induce different degrees of clustering
GPVI-clustering in fixed platelets spread on the different collagenous substrates was quantitated using dSTORM, which has a typical x-y resolution of 20-30 nm (24, 25) .
Widefield TIRF imaging of the platelets labelled for F-actin and GPVI dimer show the same distribution of GPVI as that observed in the live-cell imaging ( Fig. 2A ). Cluster analysis of dSTORM data is represented by the heat maps in Fig.2A . High and low levels of GPVIclustering are seen as red and blue, respectively. All collagenous substrates induced more GPVI-clustering than expected to occur randomly; however, the cluster distribution depended upon the specific substrate. Horm induced high degrees of clustering along the fibres, whereas the other substrates induced clusters more evenly distributed throughout the ROI. Quantification shows that there are more GPVI dimers and a greater number of clusters found per unit area on platelets spread on Col III than on the other substrates ( 
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2E, median values). Horm induced the next highest amount of GPVI dimer per ROI, 42%
less than Col III, and Horm-induced clusters were 31% less dense than those on Col III.
CRP-XL and III-30 were least effective in dimer formation (each with ~70% fewer molecules detected in the ROI compared to Col III) and cluster densities were also correspondingly reduced when compared to Col III (40% and 37% reduction, respectively). The size of GPVI-dimer clusters formed on Horm and CRP are not significantly different from each other but were significantly larger than those formed on Col III and III-30 ( Fig. 2D) . In summary, all collagenous substrates cause GPVI dimers to cluster, but different numbers of dimers and densities of GPVI within clusters are formed, depending on the nature of the collagenous substrate.
GPVI dimers are not restricted to the platelet membrane in direct contact with the visible collagen fibres (Figs. 1A, 2A). Potential explanations for this are the existence of "non visible" microfibers in those areas, to which GPVI-dimers can still bind, and/or fibrinogen or other substances released from adhered platelets may induce cluster formation via outsidein signalling. To determine whether GPVI clusters can form by collagen-independent platelet activation, platelets were spread on fibrinogen and clustering of GPVI dimer quantified using dSTORM (Fig 3) . GPVI-dimer clusters seen on fibrinogen differ from those seen on Horm collagen: relative density of dimers in platelets spread on fibrinogen is ~50% less when compared to platelets spread on Horm ( Fig 3B) ; there are many more small clusters on the fibrinogen, and the small clusters are ~40% less dense than those formed on Horm (3C-E).
Although it is possible that GPVI-dimer clustering can occur by a GPVI-independent mechanism, collagen greatly increases the formation of GPVI dimers, which coalesce into larger and denser clusters.
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Relationship between clustered GPVI-dimers and other receptors involved in the plateletcollagen interaction
Localisations of other receptors involved in the platelet-collagen interaction, GPIb (Fig. 4A) and integrin 2β1 (Fig. 4B) , were compared to that of GPVI-dimer clusters on platelets adhered to collagenous substrates. GPVI-dimer clusters form along Horm collagen fibres, whereas they appeared throughout the lamellipodia of platelets spread on Col III and III-30.
Like GPVI-dimer clusters, α2β1 was also found to localize along Horm collagen fibres, but was confined to the cell body of platelets adhered to Col III and III-30; no co-localisation with GPVI-dimer clusters was observed on the platelet lamellipodia. GPIb (VWF receptor) did not associate with GPVI-dimer clusters in the lamellipodia of any of the collagenous substrates tested, remaining in the platelet cell body.
Contribution of collagen receptor integrin α2β1 to platelet adhesion and GPVI-dimer cluster formation
Platelets labelled with Alexafluor 488-204-11 Fab with or without Gi9 (α2β1-blocking antibody), were allowed to settle onto immobilized non-fibrous collagen III or Horm fibres, and monitored by TIRFM. Gi9 treatment prevented platelet adhesion to collagen III, but merely decreased the extent of GPVI-dimer cluster formation on Horm fibres (Fig. 4C ). Gi9 had no effect on platelet adhesion/cluster formation on the GPVI-specific ligands CRP-XL and III-30 (data not shown).
Effect of Src-family and Syk kinase inhibition on GPVI cluster formation
Confocal images of platelets adhered to Horm, Col III, III-30, or CRP-XL show that areas rich in phosphotyrosine co-localize with some of the GPVI-dimer clusters (Fig. 5A ), suggesting signalling is occurring in these regions. Degree of colocalization was analysed using
Pearson's correlation (Fig. 5B, right) . To investigate whether protein tyrosine phosphorylation is important in GPVI cluster formation, platelets were treated with the Syk
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This article is protected by copyright. All rights reserved. Fig. 1 shows corresponding DIC images that enable visualisation of platelet morphology in the presence and absence of the inhibitors). Despite having a reduction in spreading, discrete GPVI-dimer clusters were visible in platelets adhered to CRP XL and III-30 in the presence of PRT-060318 or PP2 (Fig. 6) .
Effect of disrupting actin dynamics on GPVI-dimerisation and clustering
Flow cytometry was used to quantify effects of drugs that inhibit actin dynamics on GPVIclustering: Cytochalasin D (cyt) and Latrunculin A (lat), actin polymerization-blockers, and Jasplakinolide (jas), F-actin stabilizer. All three inhibitors (10 μM) significantly decreased GPVI-dimer levels in resting platelets (Fig. 7A,B) . To avoid total abolition of adhesion, we Low-dose Latrunculin A disrupted the actin cytoskeleton and severely depressed cluster formation, with platelets that did adhere not spreading. Low-dose Jasplakinolide had similar but more severe effects on cluster formation, with no apparent F-actin staining, and fewer adhered, but non-spread platelets.
Discussion
GPVI-dimers constitutively present on resting platelets are the collagen-binding form of this receptor, having over 100-fold higher affinity for collagen than the monomer [9, 10] . The constitutive presence of dimers suggests that a mechanism beyond the formation of dimers may be necessary to initiate signalling through GPVI. One mechanism may be the formation of higher-order oligomers (clusters) which has been demonstrated to play an important role in the amplification, maintenance and termination of receptor signalling in many cell types
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This article is protected by copyright. All rights reserved. [27, 28] , including platelets [18, 27] . We propose that GPVI clusters which may recruit signalling molecules to facilitate platelet activation. To explore this hypothesis, we used complementary imaging methods: TIRFM, dSTORM, and confocal microscopy.
TIRFM enabled the temporal visualisation of GPVI-cluster formation at the surface of platelets spreading on collagenous substrates. After the initial contact of GPVI-dimer with the substrate, the number of GPVI-dimer clusters increases rapidly. Notably, in platelets adhered to fibrous Horm collagen, discrete clusters form along the fibres first, then throughout the surface of the spread platelet (Fig.1A) . This is consistent with GPVI-dimers interacting with the surface of the collagen fibre, forming clusters at those points, followed by signalling that induces more cluster formation in regions of the platelet not in direct contact with the visible fibre. A different clustering pattern is observed on the immobilized nonfibrous collagenous substrates, CRP-XL (Fig. 1B) and III-30 ( Fig. 1D) , which exclusively bind GPVI, and soluble Col III (Fig. 1C) , which binds GPVI and α2β1. Immobilized non-fibrous substrates are randomly-orientated triple-helical molecules and would be expected to support a different clustering pattern than Horm collagen fibers, which contain a highly organised parallel assembly of triple-helical tropocollagen molecules within the microfibrils.
This structure dictates that GPVI-binding sites will be distributed on the surface of a fibre at fixed lateral and axial intervals, and suggests that a GPVI-dimer would be able interact with neighbouring tropocollagen molecules presenting either separate or a composite binding sites [20] .
dSTORM allows single fluorophore molecules to be detected and located with very high spatial precision. Combined with cluster analysis, dSTORM allows quantitation of the number of GPVI dimer molecules and cluster number, size and density in ROIs within a spread platelet. This information permits the relative differences in GPVI clusters to be compared in platelets spread on different substrates. Horm collagen fibres induced a high degree of clustering by virtue of their structure, outlined above. The spacing and orientation of the two proposed collagen-binding grooves of GPVI-dimer might allow it to bind with increased avidity to sites on adjacent tropocollagen molecules, allowing clustering to occur
This article is protected by copyright. All rights reserved. [20] . The ability of immobilized III-30, CRP-XL, and Col III to bind GPVI will depend on the density and relative orientation of the immobilized substrate helices. CRP and III-30 contain only GPVI-binding motifs, the former having more GPVI-reactive GPO triplets per molecule, whereas immobilized soluble Col III binds both GPVI and α2β1, which may support cooperative platelet binding, since motifs for each receptor are located close together. Such differences may explain the variation in cluster density observed between the different collagenous substrates. Indeed, both Horm and Col III had significantly higher GPVI cluster density than III-30, and Col III clusters were also significantly denser than those on CRP-XL, suggesting a measurable role for 21 in these events.
On platelets adhered to non-fibrous Col III and III-30, GPIb (Fig. 4A ) and 21 (Fig. 4B) do not co-localize with the majority of the GPVI-dimer clusters, which are located in the lamellipodia of the spread platelet. However, α2β1 is indispensable for platelet binding to soluble Col III, since adhesion is severely reduced by the blocking anti-integrin α2β1 antibody Gi9. Synergism between GPVI and α2β1 has also been observed using immobilized model peptides in flowing blood thrombus deposition studies [31] . In contrast, Gi9 did not prevent platelet adhesion/cluster formation on fibrous Horm collagen, indicating that GPVI binding to the collagen fibre is much stronger than to non-fibrous substrates.
These observations are consistent with GPVI being sufficient to support platelet binding to collagen fibres but not to soluble collagen [32] . Integrin 21 was also located along Horm collagen fibres in bound platelets, and the magnified confocal images (Fig. 4B) suggest that α2β1 binds close to some of the GPVI-dimer-clusters on the fibre. The model proposed by Herr and Farndale [20] suggests that α2β1 and GPVI might bind ~10nm apart in collagen III, and inspection of the collagen I sequence suggests that similar considerations would apply to Horm collagen. Although non-activated α2β1 may bind its high affinity motif, GFOGER, in Horm fibres [33] , this is not essential for GPVI-dimer binding and clustering. However, 21 may serve to accelerate platelet adhesion to the collagen fibre [34] , thus facilitating further GPVI-clustering. Under the present static adhesion conditions, however, the distribution of
GPIb differed from that of the GPVI dimer-clusters on collagen fibres, although GPIb was observed in the platelet cell body, adjacent to the fibre (Fig. 4A) . A Mab against GPIb (SZ2) was reported to block CRP-XL-induced platelet aggregation, and GPIb to co-precipitate with GPVI in both resting and thrombin-stimulated platelets, suggesting an interaction between the two receptors [35] . Platelet adhesion to collagen under high shear requires VWF multimers, via GPIb, to tether the platelet to collagen, but our experiments are performed under static conditions in the absence of plasma VWF, so GPIb is less important.
What induces GPVI clustering? One possibility is that platelet activation induced by the initial interaction of GPVI with collagen leads to GPVI oligomerisation. However, in spite of severe inhibition of platelet spreading by the Syk inhibitor PRT-060318, limited cluster formation on all four immobilized collagenous substrates was still observed (Fig. 6, right) .
The marked inhibition of cluster formation on Col III (which lacks the high-affinity motif, GFOGER) would be due to blocking α2β1 activation, hence removing the contribution of its high affinity form to stabilize platelet binding to collagen. Src-family kinase inhibitor PP2 also inhibited platelet adhesion, but to a lesser extent than PRT-060318 (Fig. 6, middle) .
Alternatively, blockade of both Src and Syk might potently inhibit secretion [36, 37] , preventing release of active substances (including fibrinogen), thus reducing clustering via secondary signaling pathways. These results suggest that, whilst platelet adhesion and spreading is fully dependent on GPVI-mediated signalling, GPVI-cluster formation is only partly so.
Movement of membrane proteins is controlled, in part, by the cytoskeleton in other cells [38] . Inhibitors of actin dynamics at 10 μM inhibited GPVI-dimer formation in resting platelets and prevented the GPVI-dimer increase in CRP-XL-or thrombin-activated platelets (Fig.   7A,B) . At 2 μM, a threshold inhibitory concentration, there is severely limited adhesion of non-spread platelets on all 4 tested substrates, but there is evidence of residual cluster formation and disturbed actin filament distribution. These results suggest the contribution of
the peripheral membrane cytoskeleton to GPVI cluster formation, a topic for future investigation.
Although the GPVI-dimers on resting platelets are competent to bind collagen, they are not exposed to it in an uninjured vessel and the low density of GPVI-dimers in resting platelets (1500/platelet) [10] suggests that they may be too far apart to induce efficient signalling; thus platelets remain inactive, the GPVI-dimers requiring both receptor ligation and proximity to activate platelets. However, upon vessel injury, subendothelial collagen fibres are exposed to the bloodstream, and efficient platelet activation is necessary to prevent bleeding. Once a vessel is injured, the binding sites on fibres of collagen types I and III become accessible to the receptors involved in the platelet-collagen interaction GPVI, integrin α2β1, and GPIb. The proximity of GPVI-dimer binding sites on the fibre surface enable clustering of GPVI-dimers, increasing avidity and bring together necessary signalling components to initiate signalling and lead to efficient platelet activation and thrombus formation. We examined GPVI-dependent signalling in the vicinity of GPVI clusters, and whether inhibitors of GPVI-mediated signalling affected clustering. The proximity of phosphotyrosine to some of the GPVI clusters (Fig. 5) , particularly on the Horm fibres, suggests local tyrosine kinase activity. Jamasbi et al. (39) recently reported that GPVI-Fc (Revacept) bound to collagen fibres can be clustered by the addition of anti-Fc, consistent with dimers binding in close enough proximity in the collagen fiber to allow cluster formation.
Activation induces formation of more dimers, as evidenced by the increased dimer numbers in CRP-XL-or thrombin-activated platelets [10] , enabling formation of even more clusters.
Moreover, activation of platelets leads to activation of 21, increasing its affinity for collagen, causing firm adhesion. Our present study suggests that platelets have two layers of activity regulation through GPVI-conversion of monomers to high affinity dimers, and clustering of the GPVI-dimers. Clustering would serve to increase both avidity for collagen and signalling molecule recruitment, leading to efficient platelet activation during thrombus formation.
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This article is protected by copyright. All rights reserved. Alexafluor-488-204-11 labelled platelets were reacted with DMSO (vehicle), 10 μM PP2, or PRT (5 μM) and then their adhesion to immobilized collagenous substrate was followed by TIRF. PRT markedly inhibited platelet adhesion to all substrates, but the platelets that did
adhere still showed GPVI-dimer cluster formation. The effect of PP2 was weaker but similar to that of PRT. 
and then stained for F-actin with Alexa-fluor 647-phalloidin. Lat A (2 μM) and Jas (2 μM) were used at threshold inhibitory concentrations, so that platelet adhesion is not completely prevented. Images were obtained on a confocal microscope; the following images are shown: grey scale images of the GPVI-dimer and F-actin; merged images (green = GPVIdimer clusters and red = F-actin), and transmitted light images. Lat A severely inhibited the formation of large GPVI-clusters, but a limited number of small clusters could still be observed for platelet adhesion to all tested collagenous substrates. The spreading is clearly inhibited on all the collagenous substrates. Jas produced more severe inhibition of F-actin and no F-actin staining could be observed in the Jas-treated platelets. In the Jas-treated platelets, some green fluorescence could still be observed in the adhered cells, but it is not clear whether this corresponds to small GPVI-clusters or is due to the higher density of residual GPVI-dimers due to the much more compact size of the non-spread platelets. Note that in spite of the cytoskeleton being severely compromised in the inhibitor-treated platelets and the total inhibition of spreading, there is residual ability for the platelets to adhere to the collagenous substrates, possibly due to GPVI-dimers, and this is most evident in the platelets adhered along the Horm collagen fibers in the Lat A-or Jas-treated preparations. *GPVI-binding GPO triplets are shown in bold print for CRP and III-30 a Cross-linked Collagen Related Peptide (CRP-XL) was synthesized as described by Morton et al. [29] .
b Triple-helical peptide III-30 is from the Collagen Toolkit III, a set of overlapping triple helical peptides encompassing the entire Col domain of human collagen III; it was synthesized as described by Raynal et al. [30] . c Nycomed Pharma GmbH (1 mg/ml; Munich, Germany). d Koken Co., Ltd. (3 mg/ml; Tokyo, Japan)
Supplementary Movie
GPVI forms clusters when platelets spread on immobilized collagenous substrates. TIRF microscopy time course of washed human platelets, labelled with Alexa 488 labelled dimer- 
